AGIO:NASDAQ
Agios Pharmaceuticals Inc
28,72 $
arrow_downward
-0,12%(-0,035) 1D
20 қар., 09:39:27 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
28,01 $
High
28,92 $
Low
27,87 $
Mkt. cap
1,72 млрд
Avg. vol.
1,13 млн
Volume
10,00
52-wk high
44,09 $
52-wk low
23,00 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
Open
28,01 $
High
28,92 $
Low
27,87 $
Mkt. cap
1,72 млрд
Avg. vol.
1,13 млн
Volume
10,00
52-wk high
44,09 $
52-wk low
23,00 $
EPS
-6,32 $
Beta
0,66
Shares outstanding
59,81 млн
No. of employees
540
News stories
From web sources and news partners
ChartMill
·
1 сағат бұрын
S&P 500 Premarket Movers Friday: Gainers and Losers
Reuters
·
35 минут бұрын
SocGen sees S&P 500 ending 2027 at 8,500 on AI, earnings support
Coinpaper
·
3 минут бұрын
S&P 500 Price Prediction: S&P 500 Falls 2.3% Below 200-Day Average
Traders Union
·
47 минут бұрын
Ryan Detrick: S&P 500 posts six-day losing streak, longest since April 2024
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc